First Measles Cases in Chicago; Bubonic Plague Death; Tapeworm Larvae in Man’s Brain – news today


Note that some links may require registration or subscription.

The CDC sent a team to Chicago in response to the first detected measles cases in the city since 2019. (ABC News)

Data from the U.K. fall 2023 booster campaign showed divergent performance of two different COVID vaccines. (The Lancet)

Calcium and vitamin D supplements appeared to reduce cancer mortality and raise cardiovascular disease mortality in post-menopausal women after more than 20 years of follow-up. (Annals of Internal Medicine)

Prisons were not built for the growing healthcare needs of the aging prison population. (NPR)

New Mexico health officials said a local man died of the bubonic plague, the first such death since 2020. (Scripps News)

The FDA extended the approval of alirocumab (Praluent) as an adjunct to diet and low-density lipoprotein cholesterol lowering therapies to include pediatric patients with heterozygous familial hypercholesterolemia, Regeneron said.

A new proposal from the Heritage Foundation, designed for a second term of former President Donald Trump, would drastically reduce the size of the CDC by splitting the agency in two. (Politico)

Meanwhile, Trump said “there is a lot you can do” to cut funds for programs like Social Security and Medicare. (The Hill)

The FDA did not approve GA Depot, a form of glatiramer acetate, for multiple sclerosis, Viatris and Mapi Pharma said.

Tapeworm larvae presented as migraine in a case report of a U.S. man who consumed undercooked bacon. (American Journal of Case Reports)

China plans to increase the number of specialized infectious disease teams that respond to potential outbreaks by five to 25. (Reuters)

The American Academy of Dermatology voted to keep its diversity, equity and inclusion programs after a controversial campaign to have them removed. (NBC News)

Experts said leaked internal messages for an international group of transgender health professionals presented a false link between gender-affirming care and cancer. (STAT News)

The Congressional Budget Office suggested that obesity drugs like semaglutide (Wegovy) may soon be covered by Medicare, in part due to recent findings about heart benefits. (Endpoint News)

  • author['full_name']

    Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow


Source Link